Literature DB >> 23374063

Association between transient hypothyroxinaemia of prematurity and adult autism spectrum disorder in a low-birthweight cohort: an exploratory study.

Steven J Korzeniewski1, Jennifer A Pinto-Martin, Agnes H Whitaker, Judith F Feldman, John M Lorenz, Susan E Levy, Tammy Z Movsas, Athina Pappas, Nigel Paneth.   

Abstract

BACKGROUND: Transient hypothyroxinaemia of prematurity (THOP) is associated with increased risk of cerebral palsy and lower IQ in low-birthweight infants. This study explores whether THOP is also associated with increased risk of autism spectrum disorders (ASD).
METHODS: This secondary analysis uses data from a birth cohort of newborns weighing 500 -2000 g (n = 1105) who were followed to age 21 years, when they were assessed for ASD in the second of a two-stage process. Of the 187 assessed at age 21, 14 had ASD. Neonatal thyroxine results were available for 12/14 and 165/173 participants diagnosed with and without ASD, respectively. THOP was defined as thyroxine z-score <-2.6. Unadjusted relative risks (RR) and confidence intervals (CI) were calculated.
RESULTS: The mean neonatal thyroxine z-score in young adults diagnosed with ASD was 0.5 SD lower [95% CI -0.16, 1.06] than in those without ASD. Participants with THOP were at 2.5-fold greater risk of ASD (RR 2.5 [95% CI 0.7, 8.4]). While neither of these differences was statistically significant, in a secondary subgroup analysis of those whose mothers did not have hypertension during pregnancy, THOP significantly increased the RR for ASD (5.0 [95% CI 1.2, 20.5]).
CONCLUSION: While the primary relation between THOP and ASD found here is not statistically significant, the magnitude of association and significant relationship observed in the subgroup whose mothers did not have hypertension during pregnancy suggest that it is worthy of further investigation.
© 2013 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23374063      PMCID: PMC5550024          DOI: 10.1111/ppe.12034

Source DB:  PubMed          Journal:  Paediatr Perinat Epidemiol        ISSN: 0269-5022            Impact factor:   3.980


  19 in total

1.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

2.  Motor and cognitive outcomes in nondisabled low-birth-weight adolescents: early determinants.

Authors:  Agnes H Whitaker; Judith F Feldman; John M Lorenz; Sa Shen; Fiona McNicholas; Marlon Nieto; Dawn McCulloch; Jennifer A Pinto-Martin; Nigel Paneth
Journal:  Arch Pediatr Adolesc Med       Date:  2006-10

Review 3.  Thyroid hormone action during brain development: more questions than answers.

Authors:  Sigrun Horn; Heike Heuer
Journal:  Mol Cell Endocrinol       Date:  2009-09-16       Impact factor: 4.102

Review 4.  Review of animal models for autism: implication of thyroid hormone.

Authors:  Miyuki Sadamatsu; Hirohiko Kanai; Xiaobin Xu; Ying Liu; Nobumasa Kato
Journal:  Congenit Anom (Kyoto)       Date:  2006-03       Impact factor: 1.409

5.  The central New Jersey neonatal brain haemorrhage study: design of the study and reliability of ultrasound diagnosis.

Authors:  J Pinto-Martin; N Paneth; T Witomski; I Stein; S Schonfeld; D Rosenfeld; W Rose; E Kazam; R Kairam; V Katsikiotis
Journal:  Paediatr Perinat Epidemiol       Date:  1992-04       Impact factor: 3.980

6.  To use or not to use the odds ratio in epidemiologic analyses?

Authors:  M Nurminen
Journal:  Eur J Epidemiol       Date:  1995-08       Impact factor: 8.082

Review 7.  Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings.

Authors:  R T Zoeller; J Rovet
Journal:  J Neuroendocrinol       Date:  2004-10       Impact factor: 3.627

Review 8.  Neuroendocrine pathways altered in autism. Special role of reelin.

Authors:  Silvia Kelemenova; Daniela Ostatnikova
Journal:  Neuro Endocrinol Lett       Date:  2009       Impact factor: 0.765

9.  The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes.

Authors:  Jerzy Wegiel; Izabela Kuchna; Krzysztof Nowicki; Humi Imaki; Jarek Wegiel; Elaine Marchi; Shuang Yong Ma; Abha Chauhan; Ved Chauhan; Teresa Wierzba Bobrowicz; Mony de Leon; Leslie A Saint Louis; Ira L Cohen; Eric London; W Ted Brown; Thomas Wisniewski
Journal:  Acta Neuropathol       Date:  2010-03-03       Impact factor: 17.088

10.  Lack of a relation between human neonatal thyroxine and pediatric neurobehavioral disorders.

Authors:  Offie Porat Soldin; Shenghan Lai; Steven H Lamm; Shiela Mosee
Journal:  Thyroid       Date:  2003-02       Impact factor: 6.568

View more
  4 in total

1.  Maternal thyroid autoantibody and elevated risk of autism in a national birth cohort.

Authors:  Alan S Brown; Heljä-Marja Surcel; Susanna Hinkka-Yli-Salomäki; Keely Cheslack-Postava; Yuanyuan Bao; Andre Sourander
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-10-29       Impact factor: 5.067

Review 2.  Environmental factors associated with autism spectrum disorder: a scoping review for the years 2003-2013.

Authors:  M Ng; J G de Montigny; M Ofner; M T Do
Journal:  Health Promot Chronic Dis Prev Can       Date:  2017-01       Impact factor: 3.240

3.  Association between hypertensive disorders of pregnancy and risk of autism in offspring: a systematic review and meta-analysis of observational studies.

Authors:  Ruo-Ting Xu; Qing-Xian Chang; Qi-Qiong Wang; Jian Zhang; Lai-Xin Xia; Nanbert Zhong; Yan-Hong Yu; Mei Zhong; Qi-Tao Huang
Journal:  Oncotarget       Date:  2017-12-07

Review 4.  A profile and review of findings from the Early Markers for Autism study: unique contributions from a population-based case-control study in California.

Authors:  Kristen Lyall; Jennifer L Ames; Michelle Pearl; Michela Traglia; Lauren A Weiss; Gayle C Windham; Martin Kharrazi; Cathleen K Yoshida; Robert Yolken; Heather E Volk; Paul Ashwood; Judy Van de Water; Lisa A Croen
Journal:  Mol Autism       Date:  2021-03-18       Impact factor: 7.509

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.